ALEMBIC
Back to Income Statement
|
ALEMBIC Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹269 Cr | ₹191 Cr | ₹222 Cr | ₹343 Cr | ₹329 Cr |
What is the latest Consolidated Net Profit of ALEMBIC ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹269 Cr |
Mar2023 | ₹191 Cr |
Mar2022 | ₹222 Cr |
Mar2021 | ₹343 Cr |
Mar2020 | ₹329 Cr |
How is Consolidated Net Profit of ALEMBIC Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹269 Cr | 40.90 | |
Mar2023 | ₹191 Cr | -14.14 | |
Mar2022 | ₹222 Cr | -35.23 | |
Mar2021 | ₹343 Cr | 4.17 | |
Mar2020 | ₹329 Cr | - |
Compare Consolidated Net Profit of peers of ALEMBIC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALEMBIC | ₹3,473.2 Cr | -1.3% | -2.8% | 44.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹450,595.0 Cr | 2.6% | 4.5% | 49.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,089.0 Cr | 3.2% | -2.9% | 54.9% | Stock Analytics | |
CIPLA | ₹124,175.0 Cr | 2.8% | 1.5% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹114,625.0 Cr | 1.1% | 12.1% | 18.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,672.5 Cr | 1.5% | -0.1% | 41.6% | Stock Analytics |
ALEMBIC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALEMBIC | -1.3% |
-2.8% |
44.7% |
SENSEX | 1.9% |
-0.4% |
10.4% |
You may also like the below Video Courses